文献速递母胎医学产科

孤立性胎儿脐静脉曲张与宫内胎儿死亡及胎儿生长受限的关联:系统综述、Meta分析及嵌套回顾性队列研究

Isolated fetal umbilical vein varix and the association with intrauterine fetal death and fetal growth restriction: A systematic review, meta-analysis, and nested retrospective cohort study.
PubMed 文献 · Prenat Diagn · 2024-03-19

本研究结合回顾性队列与系统综述/Meta分析,评估孤立性胎儿腹腔内脐静脉曲张(i-FIUVV)胎儿的宫内胎儿死亡(IUFD)和胎儿生长受限(FGR)风险。队列中43例单胎i-FIUVV的IUFD风险为0%,与参考人群0.3%无显著差异;FGR风险为16.3%,高于欧洲报告的5%-10%。系统综述纳入513例,合并IUFD风险0.4%,FGR风险5.2%。结论认为i-FIUVV单胎至39周妊娠不增加IUFD风险,但可能与FGR相关。

要点

  • i-FIUVV单胎至39周妊娠的IUFD风险为0%,与参考人群无显著差异。
  • 队列中FGR风险16.3%,高于欧洲报告 incidence;系统综述合并FGR风险5.2%。
  • 建议进行超声生长评估同时评估i-FIUVV,39周前无需额外监测随访。

核心结论

  • 单胎i-FIUVV至39周妊娠不增加IUFD风险,但可能与FGR相关。
  • 队列FGR发生率高于合并文献(16.3% vs. 5%),但纳入研究的FGR定义不一。
  • 队列中出生体重低于第10百分位的比例显著高于参考人群。
  • 基于这些发现,作者建议进行超声生长评估同时评估i-FIUVV;39周前无需进一步监测和随访;39周后缺乏数据。

研究设计与样本

  • 回顾性队列研究,纳入阿姆斯特丹UMC胎儿医学单元2007年至2023年间所有单胎i-FIUVV胎儿,共43例。
  • 系统综述与Meta分析纳入2007年至2023年发表的合格文献,补充本回顾性队列数据,共纳入12篇文章、3篇摘要及当前队列,总计513例i-FIUVV。

主要发现

  • 队列IUFD风险0% [CI: 0%-8.2%],与参考人群0.3%无显著差异,p=1.0。
  • 队列FGR风险16.3% [CI: 6.8%-30.7%],高于欧洲报告的5%-10%。
  • 队列出生体重低于第10百分位的比例高于参考人群(23.3% vs. 9.9%,p<0.01)。
  • 系统综述合并IUFD风险0.4% [CI: 0.1%-1.7%],合并FGR风险5.2% [CI: 1.1%-21.3%]。
  • 平均分娩孕周在队列中为38.7周,合并文献中为37.6周,均未超过39周。

临床怎么用

  • 作者建议进行超声生长评估,同时评估i-FIUVV。
  • 作者认为39周妊娠前无需进一步监测和随访。
  • 39周妊娠后,缺乏i-FIUVV胎儿及其结局的数据。

局限性

  • 队列FGR发生率高于合并文献(16.3% vs. 5%),但纳入研究的FGR定义不一。
  • 39周妊娠后,缺乏i-FIUVV胎儿及其结局的数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the risk of intrauterine fetal death (IUFD) and fetal growth restriction (FGR) in fetuses with an isolated fetal intra-abdominal umbilical vein varix (i-FIUVV). METHODS: A retrospective cohort study combined with a systematic review and meta-analysis of the literature was performed. In the retrospective cohort study, all singleton fetuses with an i-FIUVV in the fetal medicine units of the Amsterdam UMC (between 2007 and 2023) were analyzed. The primary outcome measures were IUFD and FGR. The sample proportions of IUFD and FGR were depicted as risk percentages. The IUFD proportion was compared to the regional reference population and the FGR proportion was compared to the reported proportions in Europe. The secondary outcome measures were gestational age at diagnosis, initial and maximal FIUVV diameter, fetal monitoring in pregnancy, turbulent flow in the varix, thrombus formation in the varix, induction of labor, gestational age at birth, and birthweight centile. The proportion of fetuses with a birthweight below the 10th centile was compared with that of the regional reference population. The systematic review included all cases from eligible literature published between 2007 and 2023 supplemented by the data of our retrospective cohort study. In the systematic review and meta-analysis, the pooled proportions of IUFD and FGR were assessed in fetuses with i-FIUVV. RESULTS: The retrospective cohort included 43 singletons with an i-FIUVV. The IUFD risk was 0% [Confidence Interval, CI: 0%-8.2%], which did not differ significantly from 0.3% in the reference population, p = 1.0. The risk of FGR was 16.3% [CI: 6.8%-30.7%] in the studied population, which is higher than the reported incidence of FGR in Europe ranging from 5%-10%. The proportion of fetuses with birthweights below the 10th centile was higher in our cohort compared with the reference population (23.3 vs. 9.9%, p < 0.01). The systematic review included 12 articles, three abstracts, and our current cohort. In total, 513 cases with an i-FIUVV were included. The pooled risk was 0.4% [CI: 0.1%-1.7%] for IUFD and 5.2% [CI: 1.1%-21.3%] for FGR. The mean gestational age at birth did not exceed 39 weeks in neither the cohort (38.7 weeks) nor the pooled literature (37.6 weeks). CONCLUSION: An i-FIUVV in singletons is not associated with an increased IUFD risk up to 39 weeks of gestation but is possibly associated with FGR. The incidence of FGR in our cohort was higher than in the pooled literature (16.3% vs. 5%) but FGR definitions in the included studies varied. The proportion of birthweights below the 10th percentile in our cohort was significantly higher than in the reference group. Thus, based on these findings, we suggest conducting sonographic growth assessments while simultaneously assessing the i-FIUVV. No further monitoring and follow-up are indicated up to 39 weeks of gestation. After 39 weeks of gestation, data on fetuses with i-FIUVV and their outcomes are lacking.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Koorn I, Heinrich H, Nelissen A, et al. Isolated fetal umbilical vein varix and the association with intrauterine fetal death and fetal growth restriction: A systematic review, meta-analysis, and nested retrospective cohort study. Prenat Diagn. 2024. PMID: 38502055. doi:10.1002/pd.6538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。